News-Papers
Testimonial
Video Gallery
Octreotide: an active agent in epithelial ovarian carcinoma?
Published on Monday, 23 November 2015
See also Somatostatin in oncology, the overlooked evidences.
Search
Follow us...
Latest
- Melatonin in the Management of Mood and Sleep Problems Induced by Androgen Deprivation Therapy in Prostate Cancer Patients: A Randomized Double-blinded, Placebo-controlled Clinical Trial
- Mechanisms Underlying Tumor Suppressive Properties of Melatonin
- Melatonin treatment increases the transcription of cell proliferation-related genes prior to inducing cell death in C6 glioma cells in vitro
- In vitro and in vivo antitumor activity of melatonin receptor agonists
- Effect of melatonin on the cytotoxicity of chemotherapeutic drugs in human leukemia cells
- About melatonin - 1996
- Melatonin as a potential inhibitory agent in head and neck cancer
- Melatonin at the Crossroads of Oxidative Stress, Immunity, and Cancer Therapy
- Metabolic Crosstalk in Triple-Negative Breast Cancer Lung Metastasis: Differential Effects of Vitamin D and E in a Co-Culture System
- Understanding the Mechanism of Action of Melatonin, Which Induces ROS Production in Cancer Cells
- Serum 25-Hydroxyvitamin D Levels in Breast Cancer Patients: A Cross-Sectional Analysis by Molecular Tumor Subtypes
- The Role of Melatonin in Colorectal Cancer
- Assessment of the radioprotective effects of amifostine and melatonin on human lymphocytes irradiated with gamma-rays in vitro
- Effect of the preventive-therapeutic administration of melatonin on mammary tumour-bearing animals
- The role of melatonin in immuno-enhancement: potential application in cancer
- Five years survival in metastatic non-small cell lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: a randomized trial
- Dose-Dependency of Antitumor Effects of the Pineal Hormone Melatonin in Untreatable Metastatic Solid Tumor Patients
- Beneficial properties of melatonin in an experimental model of pancreatic cancer
Most Read
- The Di Bella Method (DBM)
- About melatonin - 1996
- All-trans-retinoic acid and cancer
- Biography
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- Somatostatin in oncology, the overlooked evidences
- Bibliography
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
- How effective is chemo therapy?
- Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
- Complete objective response to biological therapy of plurifocal breast carcinoma
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- Vademecum
- Frequently Asked Questions
- Declaration recommends eliminate the use of Impact factor for research evaluation
- Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
- Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer